Back Back
ERLOTINIB TABLET 100MG & 150 MG
Get Price Quote
Erlotinib Tablet is indicated for: The first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor(EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test. The maintenance treatment of patients with locally advanced or metastatic non-small cell lung cancer, whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. The treatment of patients with locally advanced or metastatic non- small cell lung cancer after failure of at least one prior chemotherapy regimen. 3s corporation is Supplier,Exporter ,Wholesaler for Erlotinib Tablet 100mg & 150 mg in India. We even offer contract manufacturing services from WHO GMP approved factories. ADDITIONAL INFORMATION Single oral doses of Erlotinib up to 1,000 mg in healthy subjects and weekly doses up to 1,600 mg in cancer patients have been tolerated. Repeated twice-daily doses of 200 mg single-agent Erlotinib in healthy subjects were poorly tolerated after only a few days of dosing. Based on the data from these studies, an unacceptable incidence of severe adverse reactions, such as diarrhea, rash, and liver transaminase elevation, may occur above the recommended dose. SIDE EFFECTS- MOST COMMON SIDE EFFECTS Metastatic NSCLC – First-Line Treatment of Patients With EGFR Mutations: Most frequent (≥30%) adverse reactions were diarrhea, asthenia, rash, cough, dyspnea, and decreased appetite. Advanced NSCLC – Maintenance Treatment: Rash and diarrhea. Rash (9%) and diarrhea (2%). Rash and diarrhea resulted in dose reductions or interruption (5% and 3%, respectively) and discontinuation (1% and 0.5%, respectively) of Erlotinib-treated patients. Advanced NSCLC – Second/Third-Line Treatment: Rash and diarrhea. Rash (9%) and diarrhea (6%). Rash and diarrhea each resulted in dose reductions (6% and 1%, respectively) and discontinuation in 1% of Erlotinib-treated patients. Advanced Pancreatic Cancer –Erlotinib Administered Concurrently with Gemcitabine: Fatigue, rash, nausea, anorexia, and diarrhea. Grade 3/4 (NCI-CTC Version 2.0) adverse reactions were rash (5%) and diarrhea (5%). Rash and diarrhea each resulted in dose reductions in 2% of patients and discontinuation in up to 1% of patients receiving Erlotinib plus gemcitabine.
ZYCEVA 100mg Tablets
Get Price Quote
Best Deals from Erlotinib Tablets
erlocip erlotinib tablet
Get Price Quote
Indications : Non-small cell lung cancer. Pancreatic cancer. Dosage : Non small cell lung cancer : 150mg once daily Pancreatic cancer : 100mg once daily Renal Impairment : Less than 9% of a single dose is excreted in the urine. No clinical studies have been conducted in patients with compromised renal function
0.0
View Profile
Erlocip 150 Tablets
Get Price Quote
ERLOCIP is a targeted therapy. Erlocip is classified as a epidermal growth factor receptor (EGFR) inhibitor – protein-tyrosine kinase inhibitor. It works by helping to stop cancer cells from growing.Erlocip Tablet – Precautions & How to UseBefore using Erlocip Tablet, inform your doctor about your current list of medications, over the counter products (e.g. vitamins, herbal supplements, etc.), allergies, pre-existing diseases, and current health conditions (e.g. pregnancy, upcoming surgery, etc.). Some health conditions may make you more susceptible to the side-effects of the drug. Take as directed by your doctor or follow the direction printed on the product insert. Dosage is based on your condition. Tell your doctor if your condition persists or worsens. Important counseling points are listed below : Breathing difficulty Contact lenses Diarrhea from this medication can be managed with loperamide Increased eye watering Intolerance to some sugars Liver or kidney problems Loss of appetite May use sunscreen or avoiding sun because skin reactions can occur or worsen with this medication Monitor kidney function Erlocip Tablet – Drug InteractionsIf you use other drugs or over the counter products at the same time, the effects of Erlocip Tablet may change. This may increase your risk for side-effects or cause your drug not to work properly. Tell your doctor about all the drugs, vitamins, and herbal supplements you are using, so that you doctor can help you prevent or manage drug interactions. Erlocip Tablet may interact with the following drugs and products: Atazanavir Clarithromycin Erythromycin Indinavir Itraconazole Ketoconazole Nefazodone Nelfinavir
Erlocip-150 Tablets
Get Price Quote
We have cordial relations with the logistic companies that allow us to reach any preferred Mumbai(India) with ease, thus ensuring timely delivery. Sourced from trustworthy vendors, our entire lot of raw materials has been cross checked against varied quality parameters before using them in the production process.
Erlonat Tablets
1,500 Per Bottle
1 Bottle (MOQ)
Post Free Ad
